Evaluation of the Effectiveness and Safety Profile of First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy in Pulmonary Sarcomatoid Carcinoma
He Du, Xinyu Song, Fengying Wu Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, People’s Republic of ChinaCorrespondence: Fengying Wu, Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 2004...
Saved in:
| Main Authors: | Du H, Song X, Wu F |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Lung Cancer: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/evaluation-of-the-effectiveness-and-safety-profile-of-first-line-immun-peer-reviewed-fulltext-article-LCTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Sarcomatoid Carcinoma Initially Misdiagnosed as Aspergillosis: A Diagnostic Challenge
by: YingYing Qian
Published: (2025-05-01) -
Rare transformation from lung adenocarcinoma to sarcomatoid carcinoma mediates resistance to inhibitors targeting different driver oncogenes
by: Lanlan Pang, et al.
Published: (2025-02-01) -
Carcinoma sarcomatoide glótico
by: Miguel Alberto Rodríguez-Pérez
Published: (2011-06-01) -
Integrated molecular characterization of sarcomatoid hepatocellular carcinoma
by: Rong-Qi Sun, et al.
Published: (2025-04-01) -
Successful treatment of advanced Birt-Hogg-Dubé syndrome-associated renal cell carcinoma with sarcomatoid dedifferentiation using anlotinib combined with PD-1 inhibitor after first-line therapy failure: a case report
by: Liqi Yi, et al.
Published: (2025-07-01)